These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36434955)

  • 1. Mesenchymal stem cells loaded with Ad5-Ki67/IL-15 enhance oncolytic adenovirotherapy in experimental glioblastoma.
    Wang P; Zhang J; Zhang Q; Liu F
    Biomed Pharmacother; 2023 Jan; 157():114035. PubMed ID: 36434955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syngeneic mesenchymal stem cells loaded with telomerase-dependent oncolytic adenoviruses enhance anti-metastatic efficacy.
    Yang ML; Hu CY; Lee YC; Chang CC; Chen YC; Lee PR; Su BH; Chen PC; Shiau AL; Shieh GS; Wu CL; Wu P
    Stem Cells Transl Med; 2024 Aug; 13(8):738-749. PubMed ID: 38864209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma.
    Huang J; Zheng M; Zhang Z; Tang X; Chen Y; Peng A; Peng X; Tong A; Zhou L
    Cancer Immunol Immunother; 2021 Sep; 70(9):2453-2465. PubMed ID: 33543339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment.
    Zhang Q; Zhang J; Wang P; Zhu G; Jin G; Liu F
    Stem Cell Res Ther; 2022 Jun; 13(1):284. PubMed ID: 35765095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic administration of mesenchymal stem cells loaded with a novel oncolytic adenovirus carrying IL-24/endostatin enhances glioma therapy.
    Zhang J; Chen H; Chen C; Liu H; He Y; Zhao J; Yang P; Mao Q; Xia H
    Cancer Lett; 2021 Jul; 509():26-38. PubMed ID: 33819529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy.
    Mahasa KJ; de Pillis L; Ouifki R; Eladdadi A; Maini P; Yoon AR; Yun CO
    Sci Rep; 2020 Jan; 10(1):425. PubMed ID: 31949228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
    Yoon AR; Hong J; Li Y; Shin HC; Lee H; Kim HS; Yun CO
    Cancer Res; 2019 Sep; 79(17):4503-4514. PubMed ID: 31289131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.
    Martinez-Quintanilla J; He D; Wakimoto H; Alemany R; Shah K
    Mol Ther; 2015 Jan; 23(1):108-18. PubMed ID: 25352242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
    Ahmed AU; Tyler MA; Thaci B; Alexiades NG; Han Y; Ulasov IV; Lesniak MS
    Mol Pharm; 2011 Oct; 8(5):1559-72. PubMed ID: 21718006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells.
    Hammer K; Kazcorowski A; Liu L; Behr M; Schemmer P; Herr I; Nettelbeck DM
    Int J Cancer; 2015 Aug; 137(4):978-90. PubMed ID: 25604186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TS-2021, a third-generation oncolytic adenovirus that carried Ki67 promoter, TGF-β2 5'UTR, and IL-15 against experimental glioblastoma.
    Wang J; Zhang J; Zhang Q; Zhang W; Zhang Q; Jin G; Liu F
    J Med Virol; 2024 Jan; 96(1):e29335. PubMed ID: 38149454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus.
    Bolontrade MF; Sganga L; Piaggio E; Viale DL; Sorrentino MA; Robinson A; Sevlever G; García MG; Mazzolini G; Podhajcer OL
    Stem Cells Dev; 2012 Sep; 21(14):2689-702. PubMed ID: 22462538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Membrane-Coated Oncolytic Adenovirus for Targeted Treatment of Glioblastoma.
    Jia X; Wang L; Feng X; Liu W; Wang X; Li F; Liu X; Yu J; Yu B; Yu X
    Nano Lett; 2023 Dec; 23(23):11120-11128. PubMed ID: 38032110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas.
    Parker Kerrigan BC; Shimizu Y; Andreeff M; Lang FF
    Cytotherapy; 2017 Apr; 19(4):445-457. PubMed ID: 28233640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cells.
    Zhang Q; Zhang J; Tian Y; Zhu G; Liu S; Liu F
    Cell Biosci; 2020; 10():124. PubMed ID: 33133514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
    Morales-Molina A; Gambera S; Leo A; García-Castro J
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model.
    Ahmed AU; Rolle CE; Tyler MA; Han Y; Sengupta S; Wainwright DA; Balyasnikova IV; Ulasov IV; Lesniak MS
    Mol Ther; 2010 Oct; 18(10):1846-56. PubMed ID: 20588259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus.
    He X; Yao W; Zhu JD; Jin X; Liu XY; Zhang KJ; Zhao SL
    J Transl Med; 2023 Oct; 21(1):688. PubMed ID: 37789452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.